UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 103

Sortiert nach

Quality of life among germ-cell testicular cancer survivors: The effect of time since cancer diagnosis

PloS one, 2021-10, Vol.16 (10), p.e0258257-e0258257

2021

Volltextzugriff (PDF)

FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Journal of clinical oncology, 2018-05, Vol.36 (15), p.1478-1485

2018

Volltextzugriff (PDF)

Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities?

European journal of clinical pharmacology, 2022-06, Vol.78 (6), p.1029-1038

2022

Volltextzugriff (PDF)

Correlation between NK function and response to trastuzumab in metastatic breast cancer patients

Journal of translational medicine, 2008-05, Vol.6 (1), p.25-25, Article 25

2008

Volltextzugriff (PDF)

Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Therapeutic advances in medical oncology, 2021, Vol.13, p.175883592110229-17588359211022905

2021

Volltextzugriff (PDF)

Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results

Cancer science, 2010-11, Vol.101 (11), p.2448-2454

2010

Volltextzugriff (PDF)

Subfertility and Risk of Testicular Cancer in the EPSAM Case-Control Study

PloS one, 2016-12, Vol.11 (12), p.e0169174-e0169174

2016

Volltextzugriff (PDF)

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial

BMC cancer, 2019-03, Vol.19 (1), p.283-9, Article 283

2019

Volltextzugriff (PDF)

Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study

Therapeutic advances in medical oncology, 2019, Vol.11, p.1758835919877725-1758835919877725

2019

Volltextzugriff (PDF)

Osteonecrosis of the jaw after zoledronic acid and denosumab treatment

Journal of clinical oncology, 2011-06, Vol.29 (17), p.e521-e522

2011

Volltextzugriff (PDF)

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network

BMC cancer, 2009-11, Vol.9 (1), p.388-388, Article 388

2009

Volltextzugriff (PDF)

Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel

EJD. European journal of dermatology, 2012-11, Vol.22 (6), p.758-761

2012

Volltextzugriff (PDF)

68Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients

Frontiers in medicine, 2021-01, Vol.7, p.601853-601853

2021

Volltextzugriff (PDF)

Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study

Cancer medicine (Malden, MA), 2016-11, Vol.5 (11), p.3272-3281

2016

Volltextzugriff (PDF)

IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor

PloS one, 2006-12, Vol.1 (1), p.e124-e124

2006

Volltextzugriff (PDF)

Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens

Molecular cancer therapeutics, 2007-04, Vol.6 (4), p.1223-1229

2007

Volltextzugriff (PDF)

Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer

American journal of clinical oncology, 2009-02, Vol.32 (1), p.44-48

2009

Volltextzugriff (PDF)

FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic colorectal cancer (MCRC): Results of the phase III randomized TRIBE trial

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.336-336

2013

Volltextzugriff (PDF)

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild‐type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti‐BIL study)

Cancer, 2016-02, Vol.122 (4), p.574-581

2016

Volltextzugriff (PDF)

Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-03, Vol.129, p.35-40

2019

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(103)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(67)
Humans
(64)
Oncology
(55)
Male
(54)
Female
(52)
Middle Aged
(45)
Aged
(44)
Adult
(37)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Tumors
(22)
Chemotherapy
(20)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Treatment Outcome
(18)
Cancer
(17)
Aged, 80 And Over
(15)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(13)
Prognosis
(13)
Lung Neoplasms - Drug Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(20)
Tumori
(9)
Plos One
(7)
Clinical Colorectal Cancer
(3)
International Journal Of Cancer
(3)
Lung Cancer
(3)
The Lancet Oncology
(3)
American Journal Of Clinical Oncology
(2)
Annals Of Oncology
(2)
Bmc Cancer
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality of life among germ-cell testicular cancer survivors: The effect of time since cancer diagnosis

FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities?

Correlation between NK function and response to trastuzumab in metastatic breast cancer patients

Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group

Subfertility and Risk of Testicular Cancer in the EPSAM Case-Control Study

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial

Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study

Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

Osteonecrosis of the jaw after zoledronic acid and denosumab treatment

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel

68Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients

Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study

IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor

Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens

Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer

FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic colorectal cancer (MCRC): Results of the phase III randomized TRIBE trial

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild‐type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti‐BIL study)

Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer

Suchergebnisse filtern